Paying for the Flu Vaccine
By Ben Davies
As I do every winter, I recently booked an appointment for a flu vaccine. I get it for free in the UK. If I didn’t have asthma, I’d still get vaccinated, but it would cost me between £9 and £14.99. That is both an ethical error on the part of the government, and may be a pragmatic one too.
Oxford Uehiro Centre Goes DefaultVeg
By Katrien Devolder
“Britons have cut their meat consumption by 17% over the past decade but will need to double these efforts if they are to meet targets for healthy diets and sustainable food production set out in the national food strategy earlier this year”. So began an article in The Guardian last Friday.[1] The article was reporting the guidance of the National food strategy[2]—commissioned by the UK government, but developed by an independent team in 2021—which recommends that meat consumption is cut by 30% within a decade. Many scientific studies have concluded that we (i.e., richer countries) need to be even more ambitious than that, especially if we want to halt the climate crisis.[3]
The double ethical mistake of vaccinating children against COVID-19
Alberto Giubilini
Oxford Uehiro Centre for Practical Ethics
University of Oxford
Against the Joint Committee on Vaccination and Immunisation (JCVI)’s advice that did not recommend COVID-19 vaccination for children, the four Chief Medical Officers in the UK have just recommended that all children aged 12-15 should be vaccinated with the mRNA Pfizer/BioNTech vaccine.
This is a double ethical mistake, given our current state of knowledge.
Philosophical Fiddling While the World Burns
By Charles Foster
An unprecedented editorial has just appeared in many health journals across the world. It relates to climate change.
The authors say that they are ‘united in recognising that only fundamental and equitable changes to societies will reverse our current trajectory.’
Climate change, they agree, is the major threat to public health. Here is an excerpt: there will be nothing surprising here:
‘The risks to health of increases above 1.5°C are now well established. Indeed, no temperature rise is “safe.” In the past 20 years, heat related mortality among people aged over 65 has increased by more than 50%.Hi gher temperatures have brought increased dehydration and renal function loss, dermatological malignancies, tropical infections, adverse mental health outcomes, pregnancy complications, allergies, and cardiovascular and pulmonary morbidity and mortality. Harms disproportionately affect the most vulnerable, including children, older populations, ethnic minorities, poorer communities, and those with underlying health problems.’ Continue reading
We Should Vaccinate Children in High-income Countries Against COVID-19, Too
Written by Lisa Forsberg, Anthony Skelton, Isra Black
In early September, children in England, Wales and Northern Ireland are set to return to school. (Scottish schoolchildren have already returned.) Most will not be vaccinated, and there will be few, if any, measures in place protecting them from COVID-19 infection. The Joint Committee on Vaccination and Immunisation (JCVI) have belatedly changed their minds about vaccinating 16- and 17-year olds against COVID-19, but they still oppose recommending vaccination for 12-15 year olds. This is despite considerable criticism from public health experts (here, here, and here), and despite the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) declaring COVID-19 vaccines safe and effective for children aged 12 and up—Pfizer/BioNTech in the beginning of June, and Moderna the other week.
In Sweden, children returned to school in the middle of August. As in the UK, children under 16 will be unvaccinated, and there will be few or no protective measures, such as improved ventilation, systematic testing, isolation of confirmed cases, and masking. Like the JCVI in the UK, Sweden’s Folkhälsomyndigheten opposes vaccination against COVID-19 for the under-16s, despite Sweden’s medical regulatory authority, Läkemedelsverket, having approved the Pfizer and Moderna vaccines for children from the age of 12. The European Medicines Agency approved Pfizer and Moderna in May and July respectively, declaring that any risks of vaccine side-effects are outweighed by the benefits for this age group.
The end of the COVID-19 pandemic
Alberto Giubilini, Oxford Uehiro Centre for Practical Ethics and WEH, University of Oxford
Erica Charters, Faculty of History and WEH, University of Oxford
A discussion on the end of the COVID-19 pandemic is overdue. We keep hearing that ‘we are in the middle of a pandemic’. However, it is not clear what it means to be in the middle of a pandemic if we don’t know what it means for a pandemic to end. How can we know what the middle is if we don’t know what the end is?
We were given a clear date by the WHO for the start of the pandemic (11 March 2020). A few days earlier the WHO Director-General had for the first time used the term ‘epidemic’ to refer to COVID-19 outbreaks in some countries (5 March 2020). A disease is categorized as an epidemic when it spreads rapidly, with higher rates than normal, in a certain geographical area. A pandemic is an epidemic spreading over more than one continent. Thus, declaring epidemic and pandemic status is a decision based on epidemiological criteria.
By contrast, the end of an epidemic is not determined by epidemiological factors alone. Historically, epidemics end not with the end of the disease, but with the disease becoming endemic – that is, accepted and acceptable as part of normal life.
However, when and how a disease becomes normal or acceptable is primarily a social, cultural, political, and ethical phenomenon, rather than scientific or epidemiological. It is a more subtle phenomenon – and less precise – than the start of the epidemic. The end depends on how a society decides to respond to a pathogen that keeps circulating. We might well find ourselves out of this pandemic without realising when and how it happened.
So, when will this pandemic end?
No jab, no job? Vaccination requirements for care home staff
Written by Lisa Forsberg and Isra Black
Last night the Guardian was first to report that staff working in older adult care homes will be required to get vaccinated against Covid-19. According to BBC News, ‘Care staff are expected to be given 16 weeks to have the jab—or face being redeployed away from frontline care or losing their jobs’. This announcement follows news reports over the last few months that the government have been considering making Covid-19 vaccination mandatory for staff working in older adult care homes in England. As part of this process, an open consultation on vaccination for older adult care home staff was held in April and May of this year, to which we responded.
While we think a vaccination requirement for older adult care home staff may be a necessary and proportionate measure, we nevertheless have concerns about the government’s proposed policy.
Post-Normal Challenges of Covid
Written by Stephen Rainey
How to manage the inevitable disruptions to life brought about by the emergence of a viral pandemic – a question that for many seemed remote has now had us all preoccupied for well over a year. With our just-published article, entitled The Post-Normal Challenges of COVID-19: Constructing Effective and Legitimate Responses, in the Journal Science and Public Policy, Maru Mormina, Sapfo Lignou, Joseph Nguyen, Paula Larsson and I set out to investigate some of the perplexing difficulties especially relating to effectiveness and legitimacy. We examine these in the light of pandemics as wicked problems and lay out how ‘post-normal science’ can contribute to a sound pandemic response.
In any pandemic response, the measures undertaken by authorities must effective in the sense of actually addressing the viral threats. A strategy that didn’t slow the rate of viral spread, for instance, wouldn’t work and for that reason would be due criticism. The concept of legitimacy is one perhaps less easy to cash out. In any pandemic response, the measures undertaken by authorities must be legitimate in the sense of fairly and justifiably constraining liberties enjoyed prior to the viral outbreak. A strategy that placed undue or disproportionate burdens on societal sub-groups, for instance, wouldn’t be legitimate and for that reason would be due criticism. For effectiveness in a medical crisis particularly, science is an essential element of any response. Continue reading
Affiliations
Recent Comments